Market revenue in 2023 | USD 61.6 million |
Market revenue in 2030 | USD 144.9 million |
Growth rate | 13% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Sequencing & Data Analytics Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to metagenomics market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 61.53% in 2023. Horizon Databook has segmented the Italy metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing R&D investments and continuous research by scientists have boosted the demand for innovative NGS solutions in Italy. For instance, in March 2020, using Thermo Fisher Scientific’s NGS research assay, a team of Italian researchers analyzed the SARS-CoV-2 genome from specimens collected locally and suggested that the rapidly spreading virus's genome is stable. In the recent past, the Italian biotechnology industry has shown notable growth due to major academic and industrial research.
Furthermore, the increasing prevalence of cancer in the country and continuous strategic initiatives being implemented by regional players to provide innovative solutions are expected to create a lucrative environment for market growth. In June 2020, UK-based Cambridge Cancer Genomics (CCG.ai) & Nonacus Limited and Italy-based Dante Labs partnered to build an extensive and patient centric tumor profiling service. This collaboration aims to scale precision oncology by consolidating Dante Labs’ knowledge and capability in providing sequencing services, CCG.ai AI-powered software platform, and Nonacus sensitive targeted pan-cancer NGS libraries.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy metagenomics market , including forecasts for subscribers. This country databook contains high-level insights into Italy metagenomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account